Stryker EBITDA Margin 2010-2025 | SYK
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Stryker (SYK) over the last 10 years. The current EBITDA margin for Stryker as of March 31, 2025 is .
| Stryker EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $23.22B | $4.62B | 19.88% |
| 2024-12-31 | $22.60B | $4.74B | 20.97% |
| 2024-09-30 | $21.97B | $5.40B | 24.58% |
| 2024-06-30 | $21.39B | $5.24B | 24.50% |
| 2024-03-31 | $20.96B | $5.16B | 24.60% |
| 2023-12-31 | $20.50B | $4.92B | 23.98% |
| 2023-09-30 | $19.89B | $4.48B | 22.51% |
| 2023-06-30 | $19.46B | $4.34B | 22.31% |
| 2023-03-31 | $18.95B | $4.14B | 21.86% |
| 2022-12-31 | $18.45B | $3.84B | 20.81% |
| 2022-09-30 | $17.95B | $3.83B | 21.33% |
| 2022-06-30 | $17.63B | $3.58B | 20.31% |
| 2022-03-31 | $17.43B | $3.53B | 20.24% |
| 2021-12-31 | $17.11B | $3.57B | 20.89% |
| 2021-09-30 | $16.67B | $3.49B | 20.93% |
| 2021-06-30 | $16.25B | $3.74B | 23.00% |
| 2021-03-31 | $14.72B | $2.94B | 19.96% |
| 2020-12-31 | $14.35B | $3.04B | 21.15% |
| 2020-09-30 | $14.22B | $3.20B | 22.52% |
| 2020-06-30 | $14.07B | $2.97B | 21.09% |
| 2020-03-31 | $14.96B | $3.61B | 24.11% |
| 2019-12-31 | $14.88B | $3.49B | 23.45% |
| 2019-09-30 | $14.55B | $3.23B | 22.17% |
| 2019-06-30 | $14.20B | $3.17B | 22.28% |
| 2019-03-31 | $13.88B | $3.21B | 23.14% |
| 2018-12-31 | $13.60B | $3.26B | 23.97% |
| 2018-09-30 | $13.28B | $3.27B | 24.62% |
| 2018-06-30 | $13.04B | $3.20B | 24.51% |
| 2018-03-31 | $12.73B | $3.00B | 23.57% |
| 2017-12-31 | $12.44B | $2.94B | 23.62% |
| 2017-09-30 | $12.13B | $2.88B | 23.72% |
| 2017-06-30 | $11.96B | $2.82B | 23.61% |
| 2017-03-31 | $11.79B | $2.81B | 23.81% |
| 2016-12-31 | $11.33B | $2.72B | 24.03% |
| 2016-09-30 | $10.88B | $2.66B | 24.41% |
| 2016-06-30 | $10.47B | $2.50B | 23.89% |
| 2016-03-31 | $10.06B | $2.38B | 23.64% |
| 2015-12-31 | $9.95B | $2.26B | 22.70% |
| 2015-09-30 | $9.85B | $2.07B | 20.98% |
| 2015-06-30 | $9.82B | $2.13B | 21.74% |
| 2015-03-31 | $9.75B | $1.90B | 19.51% |
| 2014-12-31 | $9.68B | $1.62B | 16.79% |
| 2014-09-30 | $9.53B | $1.57B | 16.50% |
| 2014-06-30 | $9.29B | $1.25B | 13.47% |
| 2014-03-31 | $9.14B | $1.36B | 14.90% |
| 2013-12-31 | $9.02B | $1.56B | 17.33% |
| 2013-09-30 | $8.89B | $1.58B | 17.80% |
| 2013-06-30 | $8.79B | $1.85B | 20.98% |
| 2013-03-31 | $8.69B | $1.90B | 21.83% |
| 2012-12-31 | $8.66B | $2.02B | 23.31% |
| 2012-09-30 | $8.53B | $1.71B | 19.98% |
| 2012-06-30 | $8.51B | $1.79B | 20.97% |
| 2012-03-31 | $8.45B | $1.85B | 21.93% |
| 2011-12-31 | $8.31B | $1.85B | 22.22% |
| 2011-09-30 | $8.09B | $1.88B | 23.23% |
| 2011-06-30 | $7.82B | $1.88B | 24.07% |
| 2011-03-31 | $7.54B | $1.91B | 25.33% |
| 2010-12-31 | $7.32B | $1.92B | 26.19% |
| 2010-09-30 | $7.16B | $2.28B | 31.89% |
| 2010-06-30 | $7.04B | $2.21B | 31.39% |
| 2010-03-31 | $6.92B | $2.05B | 29.68% |
| 2009-12-31 | $6.72B | $1.98B | 29.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $145.370B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.390B | 27.94 |
| Boston Scientific (BSX) | United States | $154.114B | 38.58 |
| EssilorLuxottica (ESLOY) | France | $128.999B | 0.00 |
| Medtronic (MDT) | Ireland | $107.400B | 15.23 |
| Haleon (HLN) | United Kingdom | $51.375B | 29.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.537B | 0.00 |
| ResMed (RMD) | United States | $35.781B | 26.88 |
| GE HealthCare Technologies (GEHC) | United States | $32.121B | 15.25 |
| Agilent Technologies (A) | United States | $31.661B | 20.57 |
| Terumo (TRUMY) | Japan | $27.316B | 35.48 |
| Insulet (PODD) | United States | $22.872B | 89.78 |
| Koninklijke Philips (PHG) | Netherlands | $21.440B | 15.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.026B | 11.58 |
| Baxter (BAX) | United States | $15.164B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.767B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.893B | 20.51 |
| Lantheus Holdings (LNTH) | United States | $5.336B | 13.46 |
| Prestige Consumer Healthcare (PBH) | United States | $4.224B | 18.87 |
| Perrigo (PRGO) | Ireland | $3.672B | 9.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.304B | 15.05 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.068B | 25.49 |
| GN Store Nord (GNNDY) | Denmark | $2.170B | 17.98 |
| QuidelOrtho (QDEL) | United States | $2.005B | 13.79 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.61 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Acuren (TIC) | United States | $1.297B | 0.00 |
| Neogen (NEOG) | United States | $1.235B | 15.81 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Green Thumb Industries (GTBIF) | United States | $1.143B | 25.71 |
| Kestra Medical Technologies (KMTS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.74 |
| BioLife Solutions (BLFS) | United States | $0.983B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 9.14 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Owens & Minor (OMI) | United States | $0.491B | 4.07 |
| Capricor Therapeutics (CAPR) | United States | $0.466B | 0.00 |
| Surmodics (SRDX) | United States | $0.421B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.61 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.10 |
| Cresco Labs (CRLBF) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.259B | 21.87 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.213B | 0.00 |
| Quanterix (QTRX) | United States | $0.204B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| Brainsway (BWAY) | Israel | $0.193B | 51.10 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.48 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.12 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.080B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.033B | 44.71 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |